Publication: Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa
Program
KU-Authors
KU Authors
Co-Authors
Taş-Aygar, Gamze
Gönül, Muzeyyen
Özcan, İbrahim
Ayli, Mehmet Deniz
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of follicular epithelium; many comorbidities occur that disrupt the quality of life of patients. Amyloidosis is one of them. We present a case with systemic amyloidosis secondary to HS and responding positively to secukinumab therapy. Secukinumab may also be an important option for amyloidosis findings in HS patients.
Source
Publisher
Wiley
Subject
Dermatology
Citation
Has Part
Source
Dermatologic Therapy
Book Series Title
Edition
DOI
10.1111/dth.14205
item.page.datauri
Link
Rights
N/A